Literature DB >> 15033176

IGF-I and FGF-2 coordinately enhance cyclin D1 and cyclin E-cdk2 association and activity to promote G1 progression in oligodendrocyte progenitor cells.

Terra J Frederick1, Teresa L Wood.   

Abstract

A critical question in developmental neurobiology is how stem and progenitor cells interpret multiple signals to decide whether to proliferate or exit the cell cycle. Insulin-like growth factor (IGF)-I and fibroblast growth factor (FGF)-2 have known functions individually in development of neural stem cells as well as more restricted neuronal and glial progenitor cells. The goal of this study was to elucidate how IGF-I and FGF-2 coordinately regulate the cell cycle machinery in primary oligodendrocyte progenitors (OPs). IGF-I/FGF-2 synergistically increased the numbers of OP cells recruited into S phase. IGF-I enhanced FGF-2 induction of cyclin D1, activation of G(1) cyclin-cyclin-dependent kinase (cdk) complexes, and hyperphosphorylation of retinoblastoma protein (pRb). Moreover, IGF-I was required for G(2)/M progression. In contrast, FGF-2 decreased levels of the cdk inhibitor p27(Kip1) associated with cyclin E-cdk2. These studies provide a mechanistic basis for coordinate regulation of cell cycle progression in progenitor cells by multiple growth factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033176     DOI: 10.1016/j.mcn.2003.11.015

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  35 in total

Review 1.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

Review 2.  Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.

Authors:  George Bartzokis
Journal:  Neuropharmacology       Date:  2012-01-28       Impact factor: 5.250

Review 3.  Role of fibroblast growth factors in elicitation of cell responses.

Authors:  C Laestander; W Engström
Journal:  Cell Prolif       Date:  2013-12-20       Impact factor: 6.831

Review 4.  Cell cycle regulation during neurogenesis in the embryonic and adult brain.

Authors:  Arquimedes Cheffer; Attila Tárnok; Henning Ulrich
Journal:  Stem Cell Rev Rep       Date:  2013-12       Impact factor: 5.739

Review 5.  Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

6.  A Basal Tone of 2-Arachidonoylglycerol Contributes to Early Oligodendrocyte Progenitor Proliferation by Activating Phosphatidylinositol 3-Kinase (PI3K)/AKT and the Mammalian Target of Rapamycin (MTOR) Pathways.

Authors:  Oscar Gomez; Maria A Sanchez-Rodriguez; Silvia Ortega-Gutierrez; Henar Vazquez-Villa; Carmen Guaza; Francisco Molina-Holgado; Eduardo Molina-Holgado
Journal:  J Neuroimmune Pharmacol       Date:  2015-04-22       Impact factor: 4.147

7.  lncRNA Functional Networks in Oligodendrocytes Reveal Stage-Specific Myelination Control by an lncOL1/Suz12 Complex in the CNS.

Authors:  Danyang He; Jincheng Wang; Yulan Lu; Yaqi Deng; Chuntao Zhao; Lingli Xu; Yinhuai Chen; Yueh-Chiang Hu; Wenhao Zhou; Q Richard Lu
Journal:  Neuron       Date:  2016-12-29       Impact factor: 17.173

8.  TLR4 Deficiency Impairs Oligodendrocyte Formation in the Injured Spinal Cord.

Authors:  Jamie S Church; Kristina A Kigerl; Jessica K Lerch; Phillip G Popovich; Dana M McTigue
Journal:  J Neurosci       Date:  2016-06-08       Impact factor: 6.167

Review 9.  Manipulating oligodendrocyte intrinsic regeneration mechanism to promote remyelination.

Authors:  Fabien Binamé; Lucas D Pham-Van; Dominique Bagnard
Journal:  Cell Mol Life Sci       Date:  2021-05-21       Impact factor: 9.261

10.  Coordinated control of oligodendrocyte development by extrinsic and intrinsic signaling cues.

Authors:  Li He; Q Richard Lu
Journal:  Neurosci Bull       Date:  2013-03-13       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.